Mirum Pharmaceuticals (MIRM) PT Lowered to $118 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar lowered the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $118.00 (from $120.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
